Synergy Pharmaceuticals Inc (SGYP.OQ)
18 Jan 2019
Synergy Pharmaceuticals Inc is seeking a court order making more of its executives eligible for bonuses, arguing the incentive payments will help the company achieve better results at an upcoming bankruptcy auction.
Synergy Pharmaceuticals Inc, a bankrupt developer of gastrointestinal therapies, has received court approval to proceed with a plan to sell itself, with Bausch Health Companies Inc serving as a so-called stalking horse bidder.
Synergy Pharmaceuticals Inc, a developer of gastrointestinal therapies, filed for bankruptcy on Wednesday with a deal to be acquired by Canadian health products maker Bausch Health Companies Inc for $200 million in cash and assuming some liabilities.